The IMF is pleased to provide you with a broad sampling of myeloma presentations and posters from the 2004 annual meeting of the American Society of Hematology in San Diego, California. We hope you will find this material informative and useful.
Poorer Survival in Multiple Myeloma Correlates with Patients’ age and is Linked to a Higher Stage at Presentation but Prognostic Parameters Reflecting the Biology of the Myeloma Clone are not Associated with Age.
A Pilot Study Evaluating the Safety and Efficacy of AMD3100 for the Mobilization and Transplantation of HLA-Matched Sibling Donor HematopoieticStem Cells in Patients with Advanced Hematological Malignancies.
print
back to top